Showing posts with label Lipolysis. Show all posts
Showing posts with label Lipolysis. Show all posts

Saturday, September 21, 2013

Where do triglycerides come from? Part I (Updated)

This post contains sufficient updates from the original (dated 5/11/11) that I consider it more of a fully updated version vs. a bump.   This began with my intent to link to this post in an upcoming discussion of triglycerides, when I noticed that Dr. Ronald Krauss was amongst the authors.   This study originally caught my eye because of   Marc Hellerstein's name, he of DNL not a major pathway in humans fame, that I've blogged on previously.

Now I have excerpted copiously from the discussion because the authors make several points relevant to the discussion of what comprises a healthy lipid profile.  As part of updating, I am breaking those excerpts up a bit more and adding some/more emphasis and additional commentary.

Read more »

Saturday, July 6, 2013

Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.

{shhhhhhhhh .... don't tell Gary Taubes, this might just upset his 21DaySugarDetox approved green apple cart!}

You know how the story goes by now, right? In more recent lectures, Taubes is fond of using the slide below.


source
These are two quotes that Taubes cites from Lehninger's Principles of Biochemistry and he juxtaposes them to convince you how misguided such textbooks are.  How can, on the one hand fat cells "fatten" according to the action of insulin, but human beings get fat due to positive energy balance?   The simple answer is that insulin is not some renegade hormone and your pancreas is not a master organ in the body placating your rebellious adipocyte's every whim.

Yes, tis true that insulin has a stimulatory role in the storage of fatty acids by acting on LPL on the intake side, and yes, tis true that insulin "traps" those fatty acids in the adipocytes by suppressing HSL mediated lipolysis and release of same.  Sounds like a slam dunk.  If there's too much insulin, ostensibly from chronic spiking due to chronic carbohydrate consumption, the fat cells get stuck in storage mode and the horizontal growth disorder is primed for obesity!

Not so fast.  How can the results of this study be then?  Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.   The abstract, bullet-pointed for ease of reading:
  • When energy is needed, white adipose tissue (WAT) provides fatty acids (FAs) for use in peripheral tissues via stimulation of fat cell lipolysis. 
  • FAs have been postulated to play a critical role in the development of obesity-induced insulin resistance, a major risk factor for diabetes and cardiovascular disease. However, whether and how chronic inhibition of fat mobilization from WAT modulates insulin sensitivity remains elusive. 
  • Hormone-sensitive lipase (HSL) participates in the breakdown of WAT triacylglycerol into FAs. HSL haploinsufficiency and treatment with a HSL inhibitor resulted in improvement of insulin tolerance without impact on body weight, fat mass, and WAT inflammation in high-fat-diet–fed mice. 
  • In vivo palmitate turnover analysis revealed that blunted lipolytic capacity is associated with diminution in FA uptake and storage in peripheral tissues of obese HSL haploinsufficient mice. 
  • The reduction in FA turnover was accompanied by an improvement of glucose metabolism with a shift in respiratory quotient, increase of glucose uptake in WAT and skeletal muscle, and enhancement of de novo lipogenesis and insulin signalling in liver. 
  • In human adipocytes, HSL gene silencing led to improved insulin-stimulated glucose uptake, resulting in increased de novo lipogenesis and activation of cognate gene expression. 
  • In clinical studies, WAT lipolytic rate was positively and negatively correlated with indexes of insulin resistance and WAT de novo lipogenesis gene expression, respectively. 
  • In obese individuals, chronic inhibition of lipolysis resulted in induction of WAT de novo lipogenesis gene expression. 
  • Thus, reduction in WAT lipolysis reshapes FA fluxes without increase of fat mass and improves glucose metabolism through cell-autonomous induction of fat cell de novo lipogenesis, which contributes to improved insulin sensitivity.
Cliff Notes Version:  Decreased lipolysis from WAT increased skeletal muscle glucose uptake and DNL in the liver without resulting in increased WAT mass.  In the obese, suppressing WAT lipolysis induces DNL in the fat tissue.  This improves glucose metabolism.

All of the evil things you were told insulin did to you -- turning carbs to fat in your liver and fat tissue and suppressing lipolysis from fat tissue -- are actually good for you.  And the (temporary) trapping of fat in the adipose tissue improves insulin signaling and glucose handling in the skeletal muscle.  

Imagine that ...


Tuesday, May 15, 2012

Energy deficit w/o LC alters resting carb oxidation and FA availability

Originally lucky post #13 made on March 23, 2010

In light of all of the "fat burning" , respiratory quotient and mitochondrial mayhem discussions of damaged metabolisms, I thought this might be a fitting post to bump to the top today.  The take home message of this study, IMO, is that the body burns what it needs to burn, and hormone levels adjust accordingly, not so much the other way around.  



Energy deficit without reducing dietary carbohydrate alters resting carbohydrate oxidation and fatty acid availability
Reduced carbohydrate (CHO) availability after exercise has a potent influence on the regulation of substrate metabolism, but little is known about the impact of fat availability and/or energy deficit on fuel metabolism when dietary CHO availability is not reduced. The purpose of this study was to determine the influence of a postexercise energy deficit, independent of CHO availability, on plasma substrate concentrations and substrate oxidation.
Read more »

Tuesday, December 27, 2011

Fat Tissue Regulation ~ Part VII: Changes in Fat Cells with Weight Loss

I came across this one a while back and found it fascinating.


In this study, 8 overweight/obese individuals (4M/4F, 30-60 y.o.a., BMI ≥ 27, otherwise healthy) were treated with a very low calorie diet (500 cal/day shakes + unlimited veggies) for 5 weeks followed by a weight stabilizing diet for 3 weeks.  Abdominal subcutaneous fat biopsies were taken before and after the 8 week intervention.  

There's a lot more here than what I'll address in this post.  I hope to return to this at some future date, but in keeping with this series, I want to focus on the fat storage portions of the study.  I have quite a bit in the pike regarding fatty acid transport and storage in various cell types.  While fatty acids can be transported into (and out of) cells by passive means, it became apparent to me a while ago that the relatively rapid clearance of fatty acids into fat cells after a meal likely involved some active transport mechanism.  As it turns out, uptake of fatty acids by adipocytes is facilitated  by a fatty acid binding protein, FABP4.  Triglycerides are stored in adipocytes (and other cells) in what are called lipid droplets, LD.  Although the name implies something like a glob of fat, the lipid droplet is "coming of age" of sorts being recognized as a metabolically active organelle within the cell in much the same way as fat tissue has long since come to be recognized as so much more than just some passive depot for caloric excesses.  This study looked at a protein known as vimentin which is possibly associated with lipid droplet formation/organization.  More on this in a bit.

The table below summarizes the metabolic markers which were assessed in Week 6 immediately following the 5 week VLCD.  


So the subjects lost an average of 9.5 kg or just over 20 lbs body weight, 7.1 kg (almost 16 lbs) of which was fat.  Now I'm sure we'll get the usual "well, the diet was so low in calories it was effectively low carb" spiel as to why this diet worked, but such shake diets often do contain more carbs than some low carbers eat in a month.  In any case, let's focus on that dastardly hormone insulin.  Imposing a significant energy deficit on the adipocytes resulted in a more than 25% decrease in fasting insulin levels (the p-value of > 0.05 would not be statistically significant) and a 7% decrease in fasting blood glucose (the p-value of about 0.01 is statistically significant).    Check out those NEFA/FFA!!    Circulating free fatty acids were almost dropped in half!!  You see, when the 8 subjects were weight stable at approximately 20 lbs heavier weights, their blood was swimming with free fatty acids -- you know, those NEFA the low carb shills claim are being locked away in your fat cells by your carb-induced insulin baths.  

Here's what else they found:
... the uptake of fatty acids seems improved because on average there is a 40% increase in the abundance of FABP4 after the intervention. ... this provides evidence that weight reduction, in particular loss of fat mass, stimulates the basal function of triglyceride storage by adipocytes.
Note the adipocyte proteins were assessed after the full 8 weeks (3 weeks energy balance) so that the effect of an energy deficit was eliminated (or at least mitigated).  From a formerly obese point of view, this is somewhat depressing news as always.   At first glance, it seems that losing weight only primes the fat cells to gain it back.  But let's pan back a bit and look at this whole picture of the purpose of our fat cells:  to store energy for when we need it and keep excessive levels from circulation.  So this is actually good news!  Just 5 weeks and adipose tissue is dramatically transformed from overfilled and dysfunctional to doing it's thang protecting your non-adipose tissue from metabolic damage!

But here we see yet another contradiction in the woefully misguided TWICHOO.  Yes, folks, what happens when you lower insulin, as was done in this study?  The fat cells seem to have established a more fat-accumulation friendly environment upregulating FABP4.  But something else also happens, what is described as "a reduced intracellular scaffolding of GLUT4"  Hmmmm.  So fewer glucose transporters but more fatty acid transporters.  Remind me again what we store in our fat cells?   Perhaps some comedians should stick to their day jobs rather than formulating garbage theories about how our fat mass expands to accomodate glucose.  Sigh.  But to sum up:

  • Before:  Higher insulin, higher GLUT4 scaffolding (to support glucose transport), lower FABP4 (to facilitate fatty acid uptake), elevated circulating NEFA.
  • After:  Lower insulin, lower GLUT4 scaffolding, higher FABP4, lower circulating NEFA.
Fat cells don't go wild accumulating fatty acids, rather they're fed up and just can't take it anymore!  OK, sarcasm aside, this is yet another study that shows some rather dramatic changes in metabolic health with relatively minor changes in weight.  I believe the findings here are important with respect to hormones and circulating metabolites.  Although not statistically significant (probably due more to the small sample size and variation in levels than anything), the observed drop in fasting insulin levels of 25% is physiologically significant, and yet this was accompanied by an only 7% reduction in fasting glucose.  What, yet again, seems to have changed the most?  Those NEFA.  

I'm going to save my analysis of Keith Frayn's latest review paper for the new year, but the findings here dovetail nicely with Frayn's more recent thinkings on fatty acids.  Specifically, that adipocyte IR on the release side (inefficient suppression of  HSL )  may be less important in the etiology of metabolic syndrome and diabetes, but rather that the defect occurs at the uptake side of the equation.  This leads to inappropriately elevated basal circulating free fatty acids as well as inappropriately elevated postprandial NEFA with the composition of said fatty acids being potentially troublesome.   Both lead to too much fatty acid storage in inappropriate places.   Metabolically healthy lean individuals would have highly responsive fat tissue, presumably with sufficient FABP levels to whisk fat out of the bloodstream when called upon.  That the obese have less fat accumulating proteins than their leaner selves is also in contrast to TWICHOO.  The leaner "after" folks here had a more fat-trapping milieu than their "before" situations.  The lean generally trap fat very  efficiently (though some with insufficient adipose tissue do not).  Clearly, the individual components of what drives fat uptake/esterification and lipolysis/release, do not regulate the NET accumulation of fat.   This study adds to the evidence in support of this statement.

Before I go ... speaking of Frayn ... If you're relatively new to the Asylum, you may hear his name bantied about here often, but I've not blogged all that much on his work of late.  If you don't know what I was talking about just now, may I suggest the following older blog posts (in reverse chronological order):  Fatty Acid Trafficking , Adipose tissue as a buffer for daily lipid flux ~ Keith Frayn 2002 , Non-esterified fatty acid metabolism and postprandial lipaemia , Insulin Resistance ~ Taubes v. Frayn.


Tuesday, November 8, 2011

Fat Tissue Regulation ~ Part VI: Journey & Fate of Dietary Fat

Katherine Cianflone and Sabina Paglialunga, 2006

Commonly, the dietary sources of fat exceed the actual needs and the tissues are faced with dealing with the excess. Under these circumstances, the removal process of dietary triglycerides and fatty acids becomes overloaded, resulting in excessive postprandial lipemia and accumulation of chylomicrons, remnant particles and non-esterified fatty acids. These particles are associated with disruptions in lipoprotein metabolism and changes in inflammatory factors, thus their association with cardiovascular disease, metabolic syndrome and diabetes is not surprising. Dietary factors, not just fat, influence postprandial fluxes. This leads to the question: do we need a standardized fat tolerance test?
I've been reading a lot of studies lately dealing with postprandial clearance of fats from the blood and it certainly seems to me that these are coalescing to a hypothesis that the fat tissue fails first.  Oh but CarbSane, you've been saying this for over a year now  This is news?  Well, yes, in a way.  Gratuitous third person self referencing aside, it does still appear that a breakdown in fat tissue regulation is the precipitating factor in the metabolic dysfunction cascade in the majority of cases.  However this initial breakdown appears to occur on the uptake side of the adipocyte.  Impaired fatty acid uptake by adipose tissue leads to elevated postprandial circulating NEFA that are:
  1. Excessive in the postprandial phase when they should be low, and/or 
  2. Different in composition, reflecting dietary intake, from the types of fatty acids released from stored body fat.
Read more »

Sunday, October 2, 2011

Fat Tissue Regulation: Part IV ~ How Acylation Stimulating Protein Works

Lipases are a tricky bunch of enzymes when one is looking to the action of an enzyme to extrapolate to overall regulation of fat mass.    What do lipases do?  They are enzymes that facilitate lipolysis, which is the breaking apart of triglycerides into glycerol and three fatty acids.  We have digestive lipases that break dietary triglycerides down so that they can be absorbed, but once absorbed they are packaged again back into triglycerides for transport to cells.  These triglycerides are packaged in chylomicrons.  There are lipases both in circulation and attached to all of our different cells, called lipoprotein lipases (LPL's) that break down triglycerides to free up fatty acids.  Those associated with the cells are doing so to facilitate uptake of the fatty acids.  Here's where it gets tricky, because lipases associated with, say, muscle cells, are acting to bring fatty acids into the cell to be oxidized for energy.  But the lipases associated with fat cells?  These are acting to bring fatty acids into the cells for the purposes of being re-esterified into triglyceride stores.  Then there are lipases within cells, like hormone sensitive lipase, HSL, in fat cells.  The function of this lipase is "mobilization" of fat stores -- breaking down triglycerides to release fatty acids.

If you're locked into a "fat burning" paradigm then, you want high HSL and LPL activity in fat cells and non-fat tissue cells respectively, and low adipocyte LPL activity.  Fats can't get into cells without lipolysis.  But this isn't how our human metabolism works.
Read more »

Wednesday, September 14, 2011

Diazoxide, Insulin & Obesity

In his recent post on insulin and obesity, Fat Tissue Insulin Sensitivity and Obesity , Stephan brings up one of those *nagging* studies that have been touted by TWICHOO advocates for quite some time.

Back in May 2008, Peter/Hyperlipid posted Weight loss when it's hard 2. Diazoxide.  This discusses the following study:  Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults.

What is diazoxide?  It is a drug that reduces insulin secretion.  As Peter writes:
You can simply reduce insulin secretion using diazoxide. Find enough obese people willing to put up with the hunger generating regime supplied by Slimfast and semi starve them for 8 weeks. Half can have a placebo, half get diazoxide in addition to Slimfast starvation. Figure 1 in the results is where you want to look. The idle porkers starving on Slimfast plus diazoxide lost significantly more weight in 8 weeks than the idle porkers starving on Slimfast alone.
Read more »

Sunday, September 11, 2011

Insulin Wars w/ Todd Becker Chat

Newer readers may not remember this exchange from earlier this year, but Todd Becker of Getting Stronger and I had a nice back and forth going on insulin.  Around that time this blog started to get wicked busy, a health issue with a family member was taking a lot of my time and mental energy, etc.  Long story short, despite promises made, I never got around to posting any installments from Todd's last response.  I owe Todd a huge apology for letting this slide this long.  I've got a number of other things going with this blog and related projects so really don't have the time to devote to further installments of the Insulin Wars format, so I thought I'd catch everyone up with the discussion thusfar, and share Todd's last email in full via Google docs and let things go from here!

So, here's the series thusfar:
Insulin Wars IV: Todd Becker of Getting Stronger Blog
Insulin Wars IV.1: Todd Becker of Getting Stronger blog responds
More Todd Becker (Getting Stronger blog) on Insulin
Insulin Wars IV.2a: The Discussion with Todd Becker/Getting Stronger continues


Read more »

Wednesday, August 31, 2011

Revisiting the Fatty Diets & Diabetes Study ~ How to Make Mickey Fat or Fattier


In her piece over at MDA on the How Fatty Diets Cause Diabetes, Denise Minger spent a bit of time discussing the strain of mouse used in the study.  That being the not-uncute fella you see pictured here:  A C57BL/6J mouse.   Denise describes these mice as:  "uber-susceptible to obesity, high blood sugar, insulin resistance, leptin resistance, and all that other fun stuff plaguing modern humans."  This didn't really square with my memory from when I blogged on a study involving this critter.  Took me a few minutes to remember what that blog was ... Of Mice and (Wo)Men.  That post dealt with a calorie restriction study using this same mouse.  In looking for info on this mouse, I had come across this paper:  The High-Fat Diet–Fed Mouse.  Since I was mostly looking for info on lifespan and such at the time, the subtitle didn't "hit me", that being:  A Model for Studying Mechanisms and Treatment of Impaired Glucose Tolerance and Type 2 Diabetes.  The paper describes this mouse's propensity towards obesity (and IGT and T2 diabetes) when fed a high fat (58%) diet vs. a standard low fat (11%) chow.  However, in the calorie restriction study, these mice did not become obese on standard chow (11%F, 69%C, 20%P, Teklad Global 2016).  Therefore I think it would be more fair to say that they are susceptible to diet-induced obesity (DIO), but not obesity per se on a more appropriate diet.
Read more »

Wednesday, June 1, 2011

The Myth of Starving Cells II ~ Lipolysis is not rate limiting

The low carb theory on weight loss revolves on insulin's action on adipocytes.  Specifically, high insulin favors deposition (esterification to form triglycerides) in the fat cells and suppresses lipolysis (breakdown to free fatty acids).  

This of course is true.  But the problem with this discussion is that it is incomplete.  You see, lipolysis has little to do with fat burning per se.  That is beta-oxidation occurring in the mitochondria in a series of cyclical reactions commonly called the Fatty Acid Spiral, FAS.  Free fatty acids are constantly delivered to the cells and being taken up.  Those that are not oxidized for energy are re-esterified and stored as triglycerides inside the cells (e.g. IMCL or IMCT).
Read more »

Saturday, May 21, 2011

Triglycerides: Atherosclerotic or SAD-context Biomarker?

Something that's been on my mind a lot over the past couple of years is the meaning of fasting triglycerides in the context of a low carbohydrate diet.  Many, myself included, tend to look at fasting triglycerides and HDL as more important biomarkers and these two both tend to improve rather greatly on a low carbohydrate diet.  But I've always wondered if the reduced triglycerides of LC really indicate a "reduced risk" compared to the generally higher fasting triglycerides of healthy people eating a higher carbohydrate diet.

I blogged recently about triglycerides increasing on a high carb/low fat diet.  Basically, the elevated VLDL in the high carbers was attributed to reduced clearance and not overproduction in the liver.  So I got to asking if it's the triglycerides themselves that are atherogenic or if they are merely indicative of an underlying pathology.
Read more »

Wednesday, April 27, 2011

Regional Differences in Fat Tissue Fatty Acid Regulation by Insulin

Insulin Regulation of Regional Free Fatty Acid Metabolism

Alternate Title:  Why I had a fatter ass before low carb?  :-)

This study involved 26 healthy young (21-38) non-obese (BMI 18-27) individuals split evenly by gender.  Excluded were any medications known to influence FFA metabolism.  Radiolabeled palmitate was used as a tracer for FFA's.  

All studies were initiated in the 12 hour overnight fasted state and palmitate was infused for the duration of the study.  Patients received insulin infusions of different doses (3M & 3F per group) for 150 min following baseline determinations.  Controls received a saline infusion.  Blood samples were obtained from femoral vein and artery (leg) and hepatic (liver) vein.  This was to assess systemic (whole body), leg and visceral (splanchnic) rates of appearance of FFA's  (release from adipose tissue).
Read more »

Tuesday, April 19, 2011

Insulin & Weight/Fat Loss ~ The Long and the Short of It

In the comments of my recent post, On Cherry Picking & Debunking, my "Insulin Warring" partner Todd Becker posted a multi-point commentary.  I'll get to the rest over in the comments section in that post when I get a chance, but one of his points hit on something just a little different as it goes to the core of my issue with the insulin hypothesis. (And I'm reminded I'm long overdue for an installment on the IW exchange with Todd)

In any case, here was what I said:
G&K demonstrated absolutely no correlation between fasting insulin and weight change. Therefore fasting insulin is not a factor in determining weight loss.
Todd challenged:  
Your claim that there is "no correlation" between insulin levels and weight looks only at the instantaneous correlation. But fat loss may be a delayed response, as the Woodhouse paper I linked to you indicates. Figures 1 and 2 in G&K suggest that weight either dropped or plateau'd after a slight lag in the few cases where insulin levels approached 10 uU/ml. That the weight loss continued in some cases even after insulin levels begin to increase suggests that weight regain may be a delayed metabolic response.
And
The G&K protocol used "fasting insulin" as a surrogate for basal insulin. These are not the same thing. Fasting insulin was measured twice weekly at 7-8 a.m. after a 12 hour overnight "fast". But fat loss may depend on how much of the day insulin levels remain very low. Truly low basal insulin levels may take many weeks to establish.

Read more »

Monday, March 7, 2011

Insulin, Weight & Fat Accumulation

Yes folks, if you go to any Biochemistry or Endocrinology text, you will find that insulin's action is to put fat into fat cells and suppress its release.  Therefore insulin makes us fat.  Lower insulin, lose weight.  Raise insulin, get fat.  Right?

I've recently posted on two rat studies (here and here) that demonstrate unequivocally that it is not so simple.  I've also previously addressed the study that is the focus of this post in my Insulin Wars series with Todd Becker.  But wanted to further highlight that study here in a separate post.  

Read more »

Ketogenic Diet increases Fat Mass and Fat:Total Body Mass Ratio

Ketogenic diet-fed rats have increased fat mass and phosphoenolpyruvate carboxykinase activity


This study looked at body weight, fat mass, blood lipid and glucose levels and PEPCK (rate limiting enzyme in glyceroneogenesis pathway for G3P production for esterification of fatty acids - fat deposition) activity in the liver and fat cells.  Two ad libitum diets were compared, a control standard chow and a ketogenic zero carb chow.  This study was in normal, young (30 days old at start) Wistar rats and lasted 6 weeks.

The diet compositions are shown below:
Read more »

Thursday, March 3, 2011

Another Hormone Involved in Lipid Mobilization? Atrial Natriuretic Peptide

This article is a bit heady, and I won't go into a detailed analysis but will try instead to present some relevant excerpts to the gist of this post.   That being, adipocyte metabolism, the continual cycling of fats in and out of adipose tissue, the continual cycle of esterification and hydrolysis, is mediated by more than just insulin.


According to the save date on my computer, I found this one a year ago.  Ever heard of atrial natriuretic peptide?  Me neither.  

According to Wikipedia, ANP is:
.... a powerful vasodilator, and a protein (polypeptide) hormone secreted by heart muscle cells.[1][2] It is involved in the homeostatic control of body water, sodium, potassium and fat (adipose tissue). It is released by muscle cells in the upper chambers (atria) of the heart (atrial myocytes), in response to high blood pressure. ANP acts to reduce the water, sodium and adipose loads on the circulatory system, thereby reducing blood pressure.[1]
Read more »

Tuesday, March 1, 2011

Insulin Wars IV.2a: The Discussion with Todd Becker/Getting Stronger continues

If you haven't read the discussion thus far, or just to recap, here are the links:
Insulin Wars IV: Todd Becker of Getting Stronger blog
Insulin Wars IV.1: Todd Becker of Getting Stronger blog responds
More Todd Becker (Getting Stronger blog) on Insulin (this last one links to his piece on his blog)
{Todd quoted the relevant prior exchanges in his email, so most can probably follow along just with this post}

I've been putting off posting this for too long, mostly because in its entirety it is very lengthy (15 pages!) and I haven't had the length of uninterrupted time to devote to a thorough point by point response to the entire email.  So I decided to break this installment (IV.2) up into parts (a,b..., however many) so we can keep this discussion alive and continuing.  I'm also likely to address some topics out of order from Todd's email response.   Eventually it will all get up here :-)  I very much appreciate all the hard work Todd put into his response and our continuing discussion.  Please do bear with us, as we'll no doubt get a bit repetitive at times.   I do hope you'll enjoy the complete exchange.  I appreciate any heads-up on dropped links etc. that may have occurred with my C&P.    Thanks again to Todd Becker!


1. Causal role of Insulin in fat accumulation.
Read more »

Monday, February 21, 2011

Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome

Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome

Another bookmarking post of sorts.

One interesting statement:

... in a review of 23 published studies of intervention strategies to promote loss of visceral adipose tissue... (32) concluded that individuals with greater visceral fat mass, either through an increase in body weight or the propensity to store fat in the visceral depot, lose more visceral fat when adjusted to the loss of body fat, regardless of the intervention applied (caloric restriction, pharmacological therapy, or exercise) because the visceral adipocyte has a higher lipolytic rate also in the steady state. 
For me, this makes my body fat distribution change all the more confusing, except that it does seem I'm talking more subQ belly fat than visceral in my case. 

Friday, February 11, 2011

Failure of LC/HF Diets to Suppress NEFA Release

Thanks to reader MM, I have procured a full text copy of the following study that I've discussed a bit previously:  Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet

A bullet pointed, sometimes paraphrased abstract/summary:

  • This study compared a low carb (less than 20g/day, no fat content provided but "high fat") diet to a high carb diet (55% energy, 30% fat) 
  • Fasting, 24 hour AUC (cumulative exposure) and time courses for metabolites were measured during weight loss.
  • Subjects were healthy, obese adults (n = 32; 22 women, 10 men) - diabetics and those with a history of CVD were excluded.
  • The study lasted six weeks. 
  • A 24-h in-patient feeding study was performed at baseline and after 6 wk. Glucose, insulin, free fatty acids (FFAs), and triglycerides were measured hourly during meals, at regimented times. Remnant lipoprotein cholesterol was measured every 4 h.
  • Results:
  • Patients lost a similar amount of weight in both groups 
  • There was no difference between groups on fasting triglycerides or on remnant lipoprotein cholesterol, which was the main outcome. 
  • Fasting insulin decreased, and both fasting and 24-h FFAs  increased within the High Fat group. 
  • Twenty-four-hour insulin decreased for both groups. 
  • Fasting LDL cholesterol decreased in the High Carb group only.
  • In both groups, the differences in fasting and 24-h FFAs at 6 wk were significantly correlated with the change in LDL cholesterol.
  • Conclusions: Weight loss was similar between diets, but only the high-fat diet increased LDL-cholesterol concentrations. This effect was related to the lack of suppression of both fasting and 24-h FFAs.

Read more »

Wednesday, February 9, 2011

Non-esterified fatty acid metabolism and postprandial lipaemia


Yet another gem from ... who else? ... Keith Frayn!

Non-esterified fatty acids (NEFA, or free fatty acids) are an important metabolic fuel. Both the concentration of NEFA and their flux through the circulation vary widely from hour to hour, reflecting nutritional state and physical activity. Inappropriately elevated plasma NEFA concentrations may have a number of adverse effects on both carbohydrate and lipid metabolism.
As my regular readers know well, this is a focus of my research.
These adverse effects are likely to be most marked in the postprandial period, when NEFA release from adipose tissue is usually suppressed. Although the regulation of NEFA release in the postabsorptive state is well understood in molecular terms, the predominant pathway for release of NEFA in the postprandial state is the action of lipoprotein lipase (LPL) in adipose tissue capillaries on chylomicron-triacylglycerol (TG). Fatty acids released by LPL may either be sequestered in the adipocytes by esterification, or released as NEFA into the plasma. The regulation of this branch-point, which may be of crucial significance for postprandial metabolism, is not well understood. Factors stimulating tissue retention of fatty acids include insulin and acylation stimulating protein.
1998 Keith Frayn
Read more »